Makale detayı · 2023 · article
Empagliflozin and sacubitril/valsartan reverse methotrexate cardiotoxicity by repressing oxidative stress and hypoxia in heart embryonic H9c2 cardiomyocytes – the role of morphology of mitochondria observed on electron microscopy
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıEur Rev Med Pharmacol Sci
- Katalog eşleşmesi (ISSN)European Review for Medical and Pharmacological Sciences (discontinued)
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
OBJECTIVE: Oxidative stress and hypoxia play an important role in the pathogenesis of various cardiovascular diseases. We aimed to evaluate the effectiveness of sacubitril/valsartan (S/V) and Empagliflozin (EMPA) on hypoxia-inducible factor-1α (HIF-1α) and oxidative stress in H9c2 rat embryonic cardiomyocyte cells. MATERIALS AND METHODS: BH9c2 cardiomyocyte cells were treated with methotrexate (MTX) (10-0.156 μM), empagliflozin (EMPA; 10-0.153 µM) and sacubitril/valsartan (S/V; 100-1.062 µM) for 24, 48 and 72 h. The half maximum inhibitory concentration (IC50) and half maximum excitation concentration (EC50) values of MTX, EMPA and S/V were determined. The cells under investigation were exposed to 2.2 μM MTX before treatment with 2 μM EMPA and 25 μM S/V. The cell viability, lipid peroxidation, oxidation of proteins and antioxidant parameters were measured while morphological changes were also observed by transmission electron microscopy (TEM). RESULTS: The results showed that treatment with 2 µM EMPA, 25 µM S/V or their combination produced a protective effect against the reduction in cell viability caused by 2.2 µM MTX. While HIF-1α levels plunged to their lowest with S/V treatment, oxidant parameters dipped, and antioxidant parameters soared to their highest level with S/V and EMPA combination treatment. A negative correlation was found between HIF-1α and total antioxidant capacity in the S/V treatment group. CONCLUSIONS: A significant decrease in HIF-1α and oxidant molecules together with an enhancement in antioxidant molecules and normalization of the mitochondria morphology as observed on electron microscopy in S/V and EMPA-treated cells were detected. Although S/V and EMPA have both protective effects against cardiac ischemia and oxidative damage, this effect may be increased more with S/V treatment alone compared to combined treatment.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
14atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 9 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2025 SGLT2 inhibitors: how do they affect the cardiac cellsAtıf 9 · OpenAlex
- 2024 Effect of dapagliflozin on oxidative stress in heart embryonic H9c2 cardiomyocytesAtıf 3 · OpenAlex
- 2024 Effect of dapagliflozin on oxidative stress in heart embryonic H9c2 cardiomyocytesAtıf 3 · OpenAlex
- 2024 Effects of the Methotrexate on HIF-1α, HIF-2α and P4H-TM Levels in Breast Cancer Cells: Results from an In Vitro StudyAtıf 1 · OpenAlex
- 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
- 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
- 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
- 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex
- 2025 Liraglutide Enhances Cell Viability and Reduces Oxidative Stress in Hyperglycemic H9c2 CardiomyocytesAtıf 0 · OpenAlex